Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022:1389:515-533.
doi: 10.1007/978-3-031-11454-0_18.

Gene-Targeted DNA Methylation: Towards Long-Lasting Reprogramming of Gene Expression?

Fabian M Cortés-Mancera #  1   2 , Federica Sarno #  1   3 , Désirée Goubert  1 , Marianne G Rots  4
Affiliations
Review

Gene-Targeted DNA Methylation: Towards Long-Lasting Reprogramming of Gene Expression?

Fabian M Cortés-Mancera et al. Adv Exp Med Biol. 2022.

Abstract

DNA methylation is an essential epigenetic mark, strongly associated with gene expression regulation. Aberrant DNA methylation patterns underlie various diseases and efforts to intervene with DNA methylation signatures are of great clinical interest. Technological developments to target writers or erasers of DNA methylation to specific genomic loci by epigenetic editing resulted in successful gene expression modulation, also in in vivo models. Application of epigenetic editing in human health could have a huge impact, but clinical translation is still challenging. Despite successes for a wide variety of genes, not all genes mitotically maintain their (de)methylation signatures after editing, and reprogramming requires further understanding of chromatin context-dependency. In addition, difficulties of current delivery systems and off-target effects are hurdles to be tackled. The present review describes findings towards effective and sustained DNA (de)methylation by epigenetic editing and discusses the need for multi-effector approaches to achieve highly efficient long-lasting reprogramming.

Keywords: CRISPR-dCas9; CpG methylation; DNMT; Epigenetic editing; TALE; Zinc finger.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Amabile A, Migliara A, Capasso P, Biffi M, Cittaro D, Naldini L, Lombardo A (2016) Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167:219–232 e14 - PubMed - PMC
    1. Bailus BJ, Pyles B, Mcalister MM, O’Geen H, Lockwood SH, Adams AN, Nguyen JT, Yu A, Berman RF, Segal DJ (2016) Protein delivery of an artificial transcription factor restores widespread Ube3a expression in an Angelman syndrome mouse brain. Mol Ther 24:548–555 - PubMed - PMC
    1. Becker S, Boch J (2021) TALE and TALEN genome editing technologies. Gene Genome Editing 2:100007
    1. Berdasco M, Esteller M (2019) Clinical epigenetics: seizing opportunities for translation. Nat Rev Genet 20:109–127 - PubMed
    1. Bernstein DL, Le Lay JE, Ruano EG, Kaestner KH (2015) TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts. J Clin Invest 125:1998–2006 - PubMed - PMC

LinkOut - more resources